TPO suppression was found to inhibit the proliferation and migration of NSCLC cells by regulating cyclin E1, cyclin E2, CDK2, P27, RhoA, RhoC and c‐Myc protein levels. Here, CDK2 is linked to non-small cell lung carcinoma.